The US Food and Drug Administration (FDA) approved a new medication for the treatment of attention-deficit/hyperactivity disorder (ADHD).
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Gene therapy for children with sickle cell disease approved by FDA | 5 | 7 | 08-07-2026 |
| 2 | New PILL for psoriasis approved... giving hope to millions suffering from debilitating skin condition | 0 | 5.26 | 18-03-2026 |
| 3 | Autism breakthrough as scientists find 44-cent pill that 'reverses' symptoms | 0 | 9.48 | 09-04-2026 |
| 4 | Alkermes Granted Orphan Drug Designations for Alixorexton in US, Europe | 0 | 5 | 16-06-2026 |
| 5 | FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients | 5 | 7 | 18-07-2026 |
| 6 | FDA одобрило новый противогриппозный препарат Xofluza | 0 | 0 | 25-10-2018 |
| 7 | Granules secures FTF status for CNS depressant generic | 2 | 3 | 06-07-2026 |
| 8 | Popular drug used to treat epilepsy, bipolar disorder recalled nationwide: Here's why | 0 | 4.08 | 24-07-2026 |
| 9 | Popular drug used to treat epilepsy, bipolar disorder recalled nationwide: Here's why | 0 | 4.08 | 24-07-2026 |
| 10 | New Kentucky law expands mental health treatment options, advocates say it fills critical gap | 0 | 6.33 | 17-08-2026 |